Target Price Playground
BIO.B
$389.98
Swing & Horizon Engine
Need pre-expiry P&L (+3d / +5d), multi-leg ratios, or hedged overlays on BIO.B? Launch with your exact active legs & +8.0% target.
Forward Projection
If price hits $421 by Jan 15
Multi-Option Simulator
Pre-expiry +3d/+5d & Overlays
Options Architect
Multi-leg solver & Greeks
1x1x1 Structure
Reverse Time-Diagonal + Call
๐ Strategy
Long Stock
Long Call
Long Put
Bull Call Spread
Bear Put Spread
Bear Call Credit Spread
Bull Put Credit Spread
Covered Call
Protective Put
Cash-Secured Put
Diagonal Put Spread
Long Straddle
Own stock, sell OTM call for income. Caps upside.
๐ฏ Target
1-Click Institutional Target Anchors:
54d from today
โ๏ธ Legs
LONG 100 SHARES
@ $389.98 ยท ฮ 1.00
SHORT CALL ยท $420 ยท Jan '27
Qty 1 ยท Premium $8.04 ยท ฮ 0.3
P&L at Expiry
Stock (100 sh)
Covered Call
Now
Target
๐ก Stock vs Options at Target
If BIO.B hits $421 by Jan 15: the covered call returns +$3,806 (10.0%) on $38,194 risked, vs +$3,120 (8.0%) for 100 shares on $38,998. Options give 1.2ร capital efficiency.
๐ Expiry & Gamma Wall Alignment
Options expire Jan 15, 2027 (54 days out). P&L shown is the value at expiry if BIO.B is at $421.
๐ Projected Return
P&L if BIO.B hits $421 by Jan 15
+$3,806
+10.0% on $38,194 risked
Max Profit
+$3,806
If the stock โฅ $420 at expiry
Max Loss
โ$38,194
If stock โ $0 (minus premium received)
Break-even
$381.94
-2.06% from spot
Prob. of Profit at Expiry (PoP)
57.2%
Above breakeven ($381.94)
ยท Touch Target: 49%
Net ฮ / ฮ / V
70.1 / 15.8 / -52.07
per spread, per $1 move / day / vol pt
๐ P&L Scenarios โ what happens at different prices and dates
| BIO.B Price | Today | +3d (Nov 25) | +7d (Nov 29) | Dec 10 | Dec 28 | Jan 15 (exp) |
|---|---|---|---|---|---|---|
| $312 (-20%) | -$7,004 | -$7,002 | -$7,000 | -$6,997 | -$6,996 | -$6,996 |
| $331 (-15%) | -$5,083 | -$5,077 | -$5,069 | -$5,054 | -$5,046 | -$5,046 |
| $351 (-10%) | -$3,226 | -$3,209 | -$3,189 | -$3,140 | -$3,099 | -$3,096 |
| $370 (-5%) | -$1,503 | -$1,471 | -$1,430 | -$1,320 | -$1,179 | -$1,146 |
| $382 (-2%) | -$570 | -$528 | -$472 | -$318 | -$77 | +$24 |
| $390 (0%) โ spot | -$0 | +$48 | +$112 | +$296 | +$612 | +$804 |
| $398 (+2%) | +$523 | +$576 | +$648 | +$859 | +$1,247 | +$1,584 |
| $409 (+5%) | +$1,214 | +$1,273 | +$1,354 | +$1,594 | +$2,067 | +$2,754 |
| $421 (+8%) โ target | +$1,790 | +$1,852 | +$1,937 | +$2,190 | +$2,699 | +$3,806 |
| $429 (+10%) | +$2,112 | +$2,175 | +$2,260 | +$2,512 | +$3,013 | +$3,806 |
| $448 (+15%) | +$2,721 | +$2,778 | +$2,856 | +$3,079 | +$3,480 | +$3,806 |
| $468 (+20%) | +$3,099 | +$3,146 | +$3,209 | +$3,384 | +$3,653 | +$3,806 |
Uses BIO.B's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.